2001
DOI: 10.1034/j.1600-0536.2001.440308-18.x
|View full text |Cite
|
Sign up to set email alerts
|

Periorbital allergic contact dermatitis from oxybuprocaine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2010
2010

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…The literature includes various reports of allergy to these LA additives, 10-14 as well as reports of periorbital allergic contact dermatitis to estertype LAs (oxybuprocaine, proparacaine, tetracaine) administered in various ophthalmic agents. 15,16 Sightthreatening orbital swelling after peribulbar local anesthesia that was thought to be an allergic reaction to lidocaine or hyaluronidase has been reported. 17 The ester anesthetics are metabolized by plasma pseudocholinesterase, and during their degradation, the metabolite p-aminobenzoic acid (PABA) is formed.…”
Section: Discussionmentioning
confidence: 97%
“…The literature includes various reports of allergy to these LA additives, 10-14 as well as reports of periorbital allergic contact dermatitis to estertype LAs (oxybuprocaine, proparacaine, tetracaine) administered in various ophthalmic agents. 15,16 Sightthreatening orbital swelling after peribulbar local anesthesia that was thought to be an allergic reaction to lidocaine or hyaluronidase has been reported. 17 The ester anesthetics are metabolized by plasma pseudocholinesterase, and during their degradation, the metabolite p-aminobenzoic acid (PABA) is formed.…”
Section: Discussionmentioning
confidence: 97%